Humacyte Inc Warrant
HUMAW
HUMAW was delisted on the 25th of August, 2026.
6 hedge funds and large institutions have $113K invested in Humacyte Inc Warrant in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.28% less ownership
Funds ownership: 0.28% → 0% (-0.28%)
33% less capital invested
Capital invested by funds: $168K → $113K (-$54.7K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$6.21K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7.04K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$34 |
| 3 |
Jane Street
New York
|
-$2 |
HUMAW Hedge Fund Activity: Q3 2025 in Review
6 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q3 2025, worth a combined $113K — down 33% from $168K a quarter earlier.
Fund positioning in HUMAW was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $6.21K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $7.04K sold.
- 6 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $113K of Humacyte Inc Warrant stock for Q3 2025, down 33% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest Humacyte Inc Warrant buyer in Q3 2025 was Wolverine Asset Management, an estimated $6.21K added.
- The largest Humacyte Inc Warrant seller in Q3 2025 was Susquehanna International Group, an estimated $7.04K sold.
Based on aggregated 13F filings for Q3 2025.